Share
43 Posts.
lightbulb Created with Sketch. 1
clock Created with Sketch. 29/10/20
13:47
Share
Originally posted by dybsie:
↑
Tick Tock...Tick Tock...and eventually the pharmaceutical industry.CannaPacific is hoping to capitalise on the increasing acceptance of the medical cannabis industry, which is tipped to reach $US1.2 billion ($1.7 billion) in value by 2024.Medical conditions where cannabinoids, or CBD, is used mostly relate to pain management. CBD can be obtained through an authorised prescriber or the Special Access Scheme in Australia.Aleafia Health of Canada was also an early backer and controls 10 per cent of CannaPacific . Mr Gunning is expecting that Aleafia will follow its money by providing medical cannabis product such as oils and sprays to CannaPacific, which it then sells to patients through general practitioners.partnerships with Tasmanian Alkaloids, the University of Newcastle and Xing Technology.has a lofty goal of becoming the next GW Pharmaceuticals – a British group listed in the US with a $US3 billion market capitalisation. It is a global leader in developing cannabinoid-based registered medicines.
Expand
Weren't AC8 partnered with Tasmanian Alkaloids in the early days when they were skewed towards growing and supply rather than producing pharma products?
(20min delay)